Candel Therapeutics, Inc. (CADL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.79
Day's range
$5.17

Candel Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 10.99 M $53.84 M   33.43% 20.75%
RTW INVESTMENTS, LP 05/15/2026 6.42 M $31.47 M   100.00% 12.13%
ACORN CAPITAL ADVISORS, LLC 05/15/2026 3.50 M $17.21 M   35.55% 6.61%
BLACKROCK, INC. 05/13/2026 3.11 M $15.23 M   8.64% 5.87%
SATURN V CAPITAL MANAGEMENT LLC 05/15/2026 2.90 M $14.19 M   100.00% 5.47%
PORTOLAN CAPITAL MANAGEMENT, LLC 05/15/2026 2.89 M $14.18 M   70.72% 5.47%
05/15/2026 2.46 M $12.07 M   100.00% 4.65%
VESTAL POINT CAPITAL, LP 05/15/2026 1.13 M $5.51 M   100.00% 2.12%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.06 M $5.19 M   100.00% 2.00%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.04 M $5.07 M   5.93% 1.96%
HALTER FERGUSON FINANCIAL INC. 04/28/2026 904.05 K $4.43 M   20.85% 1.71%
STATE STREET CORP 05/15/2026 818.56 K $4.01 M   3.32% 1.55%
HEIGHTS CAPITAL MANAGEMENT, INC 05/15/2026 775.00 K $3.80 M   100.00% 1.46%
SANDS CAPITAL VENTURES, LLC 05/08/2026 405.84 K $1.99 M   0.00% 0.77%
NORTHERN TRUST CORP 05/14/2026 323.15 K $1.58 M   9.38% 0.61%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 280.45 K $1.37 M   100.00% 0.53%
05/08/2026 268.25 K $1.31 M   100.00% 0.51%
GOLDMAN SACHS GROUP INC 05/15/2026 227.52 K $1.11 M   249.58% 0.43%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 227.47 K $1.11 M   100.00% 0.43%
GHISALLO CAPITAL MANAGEMENT LLC 05/15/2026 200.00 K $980.00 K   100.00% 0.38%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 200.00 K $980.00 K   100.00% 0.38%
TANAGER WEALTH MANAGEMENT LLP 04/20/2026 198.18 K $971.06 K   0.00% 0.37%
JANUS HENDERSON GROUP PLC 05/18/2026 171.98 K $845.27 K   100.00% 0.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 166.10 K $813.89 K   444.59% 0.31%
WOODLINE PARTNERS LP 05/15/2026 156.70 K $767.83 K   100.00% 0.30%
JANE STREET GROUP, LLC 05/12/2026 151.50 K $742.35 K   14.43% 0.29%
UBS GROUP AG 05/05/2026 149.86 K $734.29 K   43.62% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 141.20 K $691.88 K   93.42% 0.27%
BANK OF NEW YORK MELLON CORP 05/05/2026 136.27 K $667.70 K   43.12% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 112.97 K $553.57 K   -17.78% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 111.72 K $547.41 K   -7.68% 0.21%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 107.21 K $525.33 K   100.00% 0.20%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 102.50 K $502.25 K   100.00% 0.19%
COMMONWEALTH EQUITY SERVICES, LLC 04/27/2026 95.40 K $467.44 K   15.85% 0.18%
TWO SIGMA INVESTMENTS, LP 05/15/2026 93.50 K $458.15 K   -5.75% 0.18%
NUVEEN, LLC 04/30/2026 93.16 K $456.47 K   0.73% 0.18%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 92.63 K $453.86 K   100.00% 0.17%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 75.10 K $367.99 K   36.30% 0.14%
CITADEL ADVISORS LLC 05/15/2026 72.67 K $356.06 K   -67.90% 0.14%
ALLIANCEBERNSTEIN L.P. 05/15/2026 69.11 K $390.47 K   0.00% 0.13%
HB WEALTH MANAGEMENT, LLC 04/27/2026 67.25 K $329.50 K   15.25% 0.13%
04/21/2026 67.15 K $317.61 K   0.60% 0.13%
LIDO ADVISORS, LLC 05/13/2026 60.26 K $295.26 K   0.09% 0.11%
BIRCHVIEW CAPITAL, LP 05/15/2026 60.00 K $294.00 K   0.00% 0.11%
ALPS ADVISORS INC 05/08/2026 59.63 K $292.18 K   32.28% 0.11%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 59.21 K $290.13 K   100.00% 0.11%
MORGAN STANLEY 05/15/2026 58.23 K $285.32 K   -56.56% 0.11%
CITADEL ADVISORS LLC 05/15/2026 54.10 K $265.09 K   -50.82% 0.10%
RHUMBLINE ADVISERS 05/12/2026 51.40 K $251.85 K   0.77% 0.10%
BANK OF AMERICA CORP /DE/ 05/18/2026 47.40 K $232.27 K   -7.57% 0.09%

Candel Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 126 institutional investors and hedge funds held shares of Candel Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 10.99 M

RTW INVESTMENTS, LP: 6.42 M

ACORN CAPITAL ADVISORS, LLC: 3.5 M

BlackRock, Inc.: 3.11 M

Saturn V Capital Management LLC: 2.9 M

Portolan Capital Management, LLC: 2.89 M

82.01% of Candel Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 45.85 M shares in the last 24 months. This purchase volume represents approximately $235.22 M in transactions.